Research graph
References from Reclassification of obstetric antiphospholipid syndrome under the 2023 ACR/EULAR criteria: risk of under-recognition in patients with non-criteria antibodies and clinical implications. Local targets link to admitted publications; unresolved targets remain external evidence.
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
10.1111/j.1538-7836.2006.01753.x · 2006 · External reference
Antiphospholipid syndrome
10.1038/nrdp.2017.103 · 2018 · External reference
Diagnosis and management of the antiphospholipid syndrome
10.1056/nejmra1705454 · 2018 · External reference
The euro-phospholipid project: epidemiology of the antiphospholipid syndrome in Europe
10.1177/0961203309106832 · 2009 · External reference
The epidemiology of antiphospholipid syndrome: a population-based study
10.1002/art.40901 · 2019 · External reference
The European registry on obstetric antiphospholipid syndrome (EUROAPS): a survey of 1000 consecutive cases
10.1016/j.autrev.2018.12.006 · 2019 · External reference
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria
10.1136/ard-2023-224609 · 2023 · External reference
Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome
10.1016/j.ejogrb.2026.115055 · 2026 · External reference
A diagnostic performance study of the 2023 ACR/EULAR classification criteria for patients with antiphospholipid syndrome from the antiphospholipid syndrome Chinese collaborative cohort presenting with suspected antiphospholipid syndrome
10.1002/art.42835 · 2024 · External reference
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: impact on clinical practice
10.1016/j.jaut.2024.103237 · 2024 · External reference
Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH
10.1111/jth.13976 · 2018 · External reference
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry
10.1093/rheumatology/kez419 · 2020 · External reference
Impact of the 2023 ACR/EULAR classification criteria in women with primary antiphospholipid syndrome during pregnancy
10.3390/diagnostics14192162 · 2024 · External reference
Assessing the sensitivity and the clinical impact of the 2023 American College of Rheumatology/EULAR classification criteria in obstetric antiphospholid syndrome: findings from a multicenter Italian cohort with a long-term follow-up
10.1002/acr.80040 · 2026 · External reference
Performance validation of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in an antiphospholipid syndrome cohort
10.1016/j.jtha.2024.02.019 · 2024 · External reference
Performance of the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome in a Mexican cohort
10.1002/art.42957 · 2024 · External reference
Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’
10.1136/ard-2023-225013 · 2024 · External reference
The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome
10.1016/j.thromres.2015.08.019 · 2015 · External reference
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review
10.1160/th13-06-0509 · 2014 · External reference
Antiphosphatidylserine/prothrombin antibodies: an update on their association with clinical manifestations of antiphospholipid syndrome
10.1055/s-0040-1705115 · 2020 · External reference
Prevalence of antiphosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: a systematic review and meta-analysis
10.1016/j.thromres.2022.04.021 · 2022 · External reference
Non-criteria antiphospholipid antibody profiles and thrombotic outcomes in a cohort of patients with systemic lupus erythematosus
10.1136/lupus-2024-001174 · 2024 · External reference
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
10.1016/j.jtauto.2021.100134 · 2021 · External reference
EULAR recommendations for the management of antiphospholipid syndrome in adults
10.1136/annrheumdis-2019-215213 · 2019 · External reference
Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study
10.1182/blood-2013-08-522623 · 2014 · External reference
ESHRE guideline: recurrent pregnancy loss: an update in 2022
10.1093/hropen/hoad002 · 2023 · External reference
